论文信息 - Molecular docking of enzyme inhibitors

Molecular docking of enzyme inhibitors

Molecular docking is a frequently used method in structure‐based rational drug design. It is used for evaluating the complex formation of small ligands with large biomolecules, predicting the strength of the bonding forces and finding the best geometrical arrangements. The major goal of this advanced undergraduate biochemistry laboratory exercise is to illustrate the importance and application of this tool. Students carry out the computational modeling of the interaction of acetylcholinesterase and its inhibitor, tacrine, and learn about the concepts of protein structure, enzyme‐inhibitor interactions, intermolecular forces, and role of molecular design in drug‐development.

[1] D. E. Clark. What has virtual screening ever done for drug discovery? , 2008, Expert opinion on drug discovery.

[2] K. Courtney,et al. A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[3] William L Jorgensen,et al. Efficient drug lead discovery and optimization. , 2009, Accounts of chemical research.

[4] G. Lushington,et al. Acetylcholinesterase: molecular modeling with the whole toolkit. , 2006, Current topics in medicinal chemistry.

[5] Vildan Alptüzün,et al. Targeting acetylcholinesterase to treat neurodegeneration , 2007, Expert opinion on therapeutic targets.

[6] A. Cavalli,et al. Structure–Activity Relationships and Binding Mode in the Human Acetylcholinesterase Active Site of Pseudo‐Irreversible Inhibitors Related to Xanthostigmine , 2009, ChemMedChem.